Evidence map›Paper›PMID 31278504›Full record

ArticleEJNMMI research2019

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [

Shiro Watanabe, Tohru Shiga, Kenji Hirata, Keiichi Magota, Shozo Okamoto, Takuya Toyonaga, Kei Higashikawa, Hironobu Yasui, Jun Kobayashi, Ken-Ichi Nishijima and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. JACS Au · 2024
    Article
  3. Article
  4. Article
  5. Eribulin improves tumor oxygenation demonstrated byEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  6. Review
  7. Article
  8. Hypoxia and the phenomenon of immune exclusion.Journal of translational medicine · 2021
    Review
  9. RepurposingTheranostics · 2021
    Article
  10. Review
  11. Influence of the scan time point when assessing hypoxia inEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  12. Approaches to PET Imaging of Glioblastoma.Molecules (Basel, Switzerland) · 2020
    Review
  13. The Roles of Hypoxia Imaging UsingJournal of clinical medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Shiro WatanabeDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Tohru ShigaDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan. tshiga@med.hokudai.ac.jp.ORCID http://orcid.org/0000-0002-3238-3507
Kenji HirataDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Keiichi MagotaDivision of Medical Imaging and Technology, Hokkaido University Hospital, Kita-14, Nishi-5, Kita-ku, Sapporo, 060-8648, Japan.
Shozo OkamotoDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Takuya ToyonagaDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Kei HigashikawaCentral Institute of Isotope Science, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Hironobu YasuiCentral Institute of Isotope Science, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Jun KobayashiDepartment of Pharmacy, Hokkaido University Hospital, Kita-14, Nishi-5, Kita-ku, Sapporo, 060-8648, Japan.
Ken-Ichi NishijimaCentral Institute of Isotope Science, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Ken IsekiDepartment of Pharmacy, Hokkaido University Hospital, Kita-14, Nishi-5, Kita-ku, Sapporo, 060-8648, Japan.
Hiroki MatsumotoResearch Centre, Nihon Medi-Physics Co., Ltd., 3-1 Kitasode, Sodegaura, 299-0266, Japan.
Yuji KugeDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Nagara TamakiDepartment of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Hokkaido University · JPHokkaido University Hospital · JPFukushima Medical University · JPNihon Medi-Physics (Japan) · JP

Funding

Japan Society for the Promotion of Science 17K10428
6 · The paper itself

Abstract

backgroundTo facilitate hypoxia imaging in a clinical setting, we developed 1-(2,2-dihydroxymethyl-3-[

resultsThe single administration of [

conclusion[

Indexed as

DosimetryHypoxiaNew tracerPET

Identifiers

PMID31278504
PMCPMC6611855
OpenAlexW2955897472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.